Seventure leads €3.5m round in LNC

Seventure reportedly invested €2m in the round. It was joined by growth capital providers IRDI, GSO Capital and Aqui-Invest. Investment company EPI originally backed LNC with a €1.5m round of funding in 2010.

The fresh capital will help fund a second round of clinical trials for LNC's products. The company will also look to invest in businesses or product portfolios that could strengthen its market position.

Company
Bordeaux-based LNC is developing medical nutrition products targeting patients suffering from metabolic pathologies (diabetes and cardio-vascular diseases). Its first four products are currently undergoing clinical development.

People
Isabelle de Crémoux led the deal for Seventure Partners. IRDI and Aqui-Invest were represented by Jean-Michel Petit and Bernard Estienne respectively.

Advisers
Equity - Cabinet Lamy et Associés, Eric Baroin, Misha Raznatovitch (Legal).
Company - Cabinet Lexco, Jérome Dufour, Martin Regeasse (Legal); KPMG, Christophe Lajarrige (Financial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Now researching
• Early-stage
• Healthcare
• France
• Seventure (SPEF)